Ticker Details
ImmunityBio, Inc. Common Stock
IPO Date:	July 27, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$7.56B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.48%
Avg Daily Range (30 D):	$0.25 | 3.23%
Avg Daily Range (90 D):	$0.39 | 5.31%

Institutional Daily Volume
Avg Daily Volume:	2.8M
Avg Daily Volume (30 D):	13.16M
Avg Daily Volume (90 D):	30.32M

Trade Size
Avg Trade Size (Sh.):	257
Avg Trade Size (Sh.) (30 D):	255
Avg Trade Size (Sh.) (90 D):	302

Institutional Trades
Total Institutional Trades:	1,957
Avg Institutional Trade:	$1.87M
Avg Institutional Trade (30 D):	$2.08M
Avg Institutional Trade (90 D):	$1.85M
Avg Institutional Trade Volume:	.36M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.26M
Avg Closing Trade (30 D):	$4.92M
Avg Closing Trade (90 D):	$6.01M
Avg Closing Volume:	429.42K

News

May 25, 2026 @ 11:22 PM IBRX DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR... Source: Rosen Law Firm

May 25, 2026 @ 1:48 PM IBRX Investors Have Opportunity to Lead ImmunityBi... Source: The Schall Law Firm

May 22, 2026 @ 10:11 PM IBRX DEADLINE NOTICE: ROSEN, NATIONALLY REGARDED I... Source: Rosen Law Firm

May 22, 2026 @ 4:48 PM IBRX 4-DAY DEADLINE ALERT: ImmunityBio (IBRX) Inve... Source: Hagens Berman

May 20, 2026 @ 4:00 PM Bronstein, Gewirtz & Grossman LLC Urges ImmunityBi... Source: Bronstein, Gewirtz & Grossman Llc

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.85	$-.62	$-.06
Diluted EPS	$-.85	$-.62	$-.06
Revenue	$140.98M	$44.21M	$38.29M
Gross Profit	$140.04M	$43.97M	$37.9M
Net Income / Loss	$-854.6M	$-632.8M	$-61.96M
Operating Income / Loss	$-261.39M	$-69.79M	$-64.68M
Cost of Revenue	$.93M	$.24M	$.38M
Net Cash Flow	$145.18M	$116.92M	$28.09M
PE Ratio